We are applying our innovative technology platform to build a leading, fully integrated global pharmaceutical company
Algorithm for product innovation
Our unique approach to product innovation focuses on identifying unmet medical needs where a clinically validated parent drug or pathway is suitable to our TransCon technologies. We call this our “algorithm.” It helps us select and advance product candidates for our ever-growing pipeline.
Leveraging this strategic approach, we currently have a pipeline of independent endocrinology rare disease product candidates in clinical development, and we are advancing oncology as a second therapeutic area of focus. We continue to expand into new therapeutic areas to address unmet patient needs.


Our vision is to create new therapies focused on making a meaningful difference in patients’ lives.